The Effect of Exercise Training on Gait and Quality of Life in Parkinson's Disease

October 3, 2012 updated by: Laval University

The Effect of Exercise Training on Gait and Quality of Life in Patients With Early Parkinson's Disease

The project aims to evaluate the effects of 24 weeks of treadmill training (TT), with and without a strengthening component, on functional mobility, gait and quality of life in patients with Parkinson's disease (PD). The rationale for a study of this type stems from the hypothesis that treadmill training may act as an external "pacemaker" and enhance some properties of gait. There is a need for larger scale randomized controlled trials comparing the effects of treadmill training to control groups that receive similar amounts of attention. To date, no study has combined TT and muscle strengthening, likely the optimal form of therapy. A kinesiologist supervises the training, 3 times per week, for a total of 72 one-hour exercise sessions. It is hypothesized that at the end of 6 months, treadmill training will considerably improve walking parameters and the well being of people with PD.

Study Overview

Study Type

Interventional

Enrollment (Actual)

35

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Quebec, Canada, G1V 0A6
        • Laval University
      • Quebec, Canada, G1S 2M5
        • Quebec Memory and Motor Skills Disorders Research Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Diagnosis of idiopathic Parkinson's disease
  • Stage of II or less on Hoehn and Yahr scale

Exclusion Criteria:

  • Having musculoskeletal impairments or having excessive pain in any joint that could limit participation in exercise program
  • Dementia (MMSE<24)
  • Having balance problems
  • Live beyond 45 minutes from Laval University

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Speed TT
Walk on treadmill with progressive increases in speed
3 sessions/week, 24 weeks. The heart rate does not exceed 75% of maximum heart rate (220-age) of the participant and that blood pressure does not exceed 250/115 mmHg. During the first week, the TT velocity was adjusted to 80% of preferential walking speed of the participant. The following week, the participant was encouraged to reach 90% and 100% in the third week. From the fourth week, subjects in the Speed TT had an increase in speed, depending on exercise tolerance of each participant. The TT velocity was increased by 0,2 km/h when the participant reached criteria.
3 sessions/week, 24 weeks. The heart rate does not exceed 75% of maximum heart rate (220-age) of the participant and that blood pressure does not exceed 250/115 mmHg. During the first week, the TT velocity was adjusted to 80% of preferential walking speed of the participant. The following week, the participant was encouraged to reach 90% and 100% in the third week. From the fourth week, the TT velocity was increased by 0,2 km/h or the incline of the walking surface of TT was increased by 1% alternately when the progression criteria were met.
Experimental: Mixed TT
Walk on treadmill with progressive increases in speed and incline
3 sessions/week, 24 weeks. The heart rate does not exceed 75% of maximum heart rate (220-age) of the participant and that blood pressure does not exceed 250/115 mmHg. During the first week, the TT velocity was adjusted to 80% of preferential walking speed of the participant. The following week, the participant was encouraged to reach 90% and 100% in the third week. From the fourth week, subjects in the Speed TT had an increase in speed, depending on exercise tolerance of each participant. The TT velocity was increased by 0,2 km/h when the participant reached criteria.
3 sessions/week, 24 weeks. The heart rate does not exceed 75% of maximum heart rate (220-age) of the participant and that blood pressure does not exceed 250/115 mmHg. During the first week, the TT velocity was adjusted to 80% of preferential walking speed of the participant. The following week, the participant was encouraged to reach 90% and 100% in the third week. From the fourth week, the TT velocity was increased by 0,2 km/h or the incline of the walking surface of TT was increased by 1% alternately when the progression criteria were met.
Active Comparator: Control
Light-intensity exercise group, work flexibility and coordination
Training of the control group was characterized by light intensity exercises. For the first three months, participants performed regular exercise involving full range of motion to enhance their flexibility. For the last three months of the training programme, participants learned elements of Tai Chi and rhythmic movements of latin dance. Participants attended two 1-h supervised sessions per week and were asked to perform each week a third session at home, based on instructions in a document offered to the control group participants

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Gait speed
Time Frame: Baseline, 3 and 6 months
This measure was recorded using the GAITrite system
Baseline, 3 and 6 months
Change in Endurance walking
Time Frame: Baseline, 3 and 6 months
This measure was recorded using the 6-minutes walk test
Baseline, 3 and 6 months
Change in Quality of life
Time Frame: Baseline, 3 and 6 months
This measure was recorded using PDQ-39
Baseline, 3 and 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Postural Balance
Time Frame: Baseline, 3 and 6 months
This measure was recorded using force platform PRO Balance Master®
Baseline, 3 and 6 months
Change in Spatiotemporal parameters of walking
Time Frame: Baseline, 3 and 6 months
This measure was recorded using the GAITrite system
Baseline, 3 and 6 months
Change in Cognitive impairment
Time Frame: Baseline, 3 and 6 months
This measure was recorded using Mini-Mental State Examination
Baseline, 3 and 6 months
Change in Fear of falling
Time Frame: Baseline, 3 and 6 months
This measure was recorded using the ABC Scale
Baseline, 3 and 6 months
Change in Depression and anxiety level
Time Frame: Baseline, 3 and 6 months
This measure was recorded using BDI-II
Baseline, 3 and 6 months
Change in Effects of symptoms and motor impairment
Time Frame: Baseline, 3 and 6 months
This measure was recorded using the UPDRS
Baseline, 3 and 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Philippe Corbeil, Laval University
  • Study Director: Alexandra Nadeau, Laval University
  • Principal Investigator: Emmanuelle Pourcher, Quebec Memory and Motor Skills Disorders Research Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2010

Primary Completion (Actual)

June 1, 2011

Study Completion (Actual)

March 1, 2012

Study Registration Dates

First Submitted

September 18, 2012

First Submitted That Met QC Criteria

October 3, 2012

First Posted (Estimate)

October 4, 2012

Study Record Updates

Last Update Posted (Estimate)

October 4, 2012

Last Update Submitted That Met QC Criteria

October 3, 2012

Last Verified

September 1, 2012

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Parkinson's Disease

Clinical Trials on Walking on treadmill

Subscribe